Has Tamara Hill, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,536 in general payments to Tamara Hill, MD across 307 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tamara Hill, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tamara Hill, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tamara Hill, MD

Dermatology · Bartlesville, OKNPI 1417934852

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 307 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations.

$5,536in general payments, 2019–2025

Across 307 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$823
AbbVie$783
Novartis$769
UCB, Inc.$554
Lilly USA, LLC$492
Pfizer$409
plus $2K from 17 others

What the payments were for

Food & beverage$5,42998%
Education$1062%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	38	$823
AbbVie(2 entities)	47	$783
Novartis	38	$769
UCB, Inc.	37	$554
Lilly USA, LLC	26	$492
Pfizer	27	$409
Amgen	16	$290
Johnson & Johnson	12	$271
Sun Pharmaceutical Industries Inc.	10	$174
Sanofi	7	$173
Galderma Laboratories, L.p.	11	$169
LEO Pharma Inc.	7	$137
E.r. Squibb & Sons, L.L.C.	6	$109
Ortho Dermatologics, A Division Of Bausch Health US, LLC	5	$73
Incyte Corporation	4	$65
Mayne Pharma Commercial LLC	3	$49
Journey Medical Corporation	2	$42
Dermavant Sciences, Inc.	2	$38
VYNE Pharmaceuticals Inc.	2	$38
Organon	4	$28
Almirall LLC	1	$20
Nabriva Therapeutics, PLC	1	$15
Sandoz	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$125

How this compares

$5,536 in reported general payments places this provider in the 55th percentile of 114 dermatology providers in Oklahoma.

See all dermatology providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$88,631

Medicare patients

328

Services billed

1,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	13	$64,512
Clobetasol Propionate	40	$1,278
ValacyclovirValacyclovir Hcl	18	$961
Metronidazole	13	$615
Ketoconazole	42	$575
Pentoxifylline	26	$532
Imiquimod	11	$446
Triamcinolone Acetonide	40	$399
Minoxidil	42	$282
Doxycycline Hyclate	11	$215
Mupirocin	28	$186
Cephalexin	15	$89
Hydrocortisone	17	$85
Prednisone	12	$40

Paid to pharmacies, not to this prescriber.

Other dermatology in Bartlesville

Kori SauerBartlesville$5K
Thomas HallStillwater$633K
George MonksTulsa$530K
Yaohan LamOklahoma City$88K
Kimberly JerdanOklahoma City$59K
Mark DawkinsOklahoma City$56K
Jeff AlexanderTulsa$41K
Johnathan LedetTulsa$37K
John AshleyTulsa$24K
Thomas UriceNorman$23K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →